ICD-10 Coding for Nausea and Vomiting(R11.0, R11.0B, R11.0N)
Explore ICD-10 codes for nausea and vomiting, including R11.0, R11.10, and R11.2. Learn about documentation requirements and coding for chemotherapy-induced symptoms.
Complete code families applicable to Nausea and Vomiting
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R11.0 | Nausea | Use when the patient experiences nausea without any vomiting. |
|
| R11.10 | Unspecified vomiting | Use when vomiting occurs without a known cause or associated nausea. |
|
| R11.2 | Nausea with vomiting | Use when both nausea and vomiting are present without an identifiable cause. |
|
| T45.1X5A | Adverse effect of chemotherapy | Use when nausea and vomiting are directly linked to chemotherapy treatment. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNausea and Vomiting
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Nausea and Vomiting.
Coding symptoms without linking to chemotherapy
Impact
Clinical: Misrepresentation of treatment effects., Regulatory: Non-compliance with coding guidelines., Financial: Potential claim denials.
Mitigation
Ensure documentation clearly links symptoms to chemotherapy., Use appropriate codes for adverse effects.
Sequencing symptoms before etiology
Impact
Reimbursement: Claims may be denied or reimbursed at a lower rate., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Always code the underlying condition first if known.
Chemotherapy-related symptoms
Impact
Failure to document linkage between symptoms and chemotherapy.
Mitigation
Ensure clear documentation of chemotherapy regimen and timing of symptoms.